Nine Square Therapeutics

A quest to alter the trajectory of neurodegenerative disease

General Information
Company Name
Nine Square Therapeutics
Founded Year
2020
Location (Offices)
South San Francisco, United States +1
Founders / Decision Makers
Number of Employees
27
Industries
Biotechnology, Health and Wellness
Funding Stage
Grant
Social Media

Nine Square Therapeutics - Company Profile

Nine Square Therapeutics:

Name: Nine Square Therapeutics Slogan: A quest to alter the trajectory of neurodegenerative disease Description: Founded by life sciences venture capital firm ATP and renowned scientists at the University of California San Francisco (UCSF), Nine Square is uniting machine learning-enabled image-based cell profiling, chemistry and computational sciences to develop more effective drugs, faster. They are building a diversified portfolio of first-in class drug candidates for genetically validated targets on the autophagy/lysosomal pathway to overcoming the historical challenges of treating severe neurodegenerative diseases. Currently advancing multiple programs through preclinical development, with lead optimization efforts underway towards IND-enabling studies. Founded: 2020 Industries: Biotechnology Headquarter: United States Last Investment: $4.50M grant investment at 12 September 2023 Last Investment Investors: The Michael J. Fox Foundation for Parkinson's Research

Nine Square Therapeutics, founded in 2020, is a biotechnology startup based in the United States. They are focused on developing more effective drugs for severe neurodegenerative diseases by leveraging machine learning-enabled image-based cell profiling and genetic targets on the autophagy/lysosomal pathway. The company received a $4.50M grant investment from The Michael J. Fox Foundation for Parkinson's Research in September 2023. Their approach, integrating chemistry and computational sciences, shows potential to alter the trajectory of neurodegenerative diseases.

Taxonomy: neurodegenerative disease, life sciences, venture capital, cell profiling, drug development, autophagy/lysosomal pathway, preclinical development, lead optimization, IND-enabling studies, genetic targets, computational sciences, University of California San Francisco, ATP, drug candidates

Funding Rounds & Investors of Nine Square Therapeutics (2)

View All
Funding Stage Amount No. Investors Investors Date
Grant $4.50M 1 12 Sep 2023
Series A $50.00M 1 01 Jul 2020

Latest News of Nine Square Therapeutics

View All

No recent news or press coverage available for Nine Square Therapeutics.

Similar Companies to Nine Square Therapeutics

View All
Shortwave Life Sciences - Similar company to Nine Square Therapeutics
Shortwave Life Sciences Pioneering Mental Health Care
Hobson Prior - Similar company to Nine Square Therapeutics
Hobson Prior Leading specialist life sciences recruiter focused on delivering made-to-measure solutions that empower innovators.
BioNJ - Similar company to Nine Square Therapeutics
BioNJ Because Patients Can't Wait®
Dr. Reddy's Institute of Life Sciences - Similar company to Nine Square Therapeutics
Dr. Reddy's Institute of Life Sciences A forefront institution dedicated to advancing life sciences through groundbreaking research and pharmaceutical innovation.
Algorithmiq - Similar company to Nine Square Therapeutics
Algorithmiq We develop advanced quantum algorithms to solve complex problems in life sciences